| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5690790 | Urology | 2017 | 4 Pages |
Abstract
To our best knowledge, this is the first time that maternal urinary CA19-9 has been used as a marker for ANH. Based on these pilot data, CA19-9 levels are significantly higher in the urine of pregnant women carrying fetuses with severe ANH, and it may have the potential to serve as a noninvasive and useful biomarker to diagnose ANH.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Abdol-Mohammad Kajbafzadeh, Sorena Keihani, Seyedeh Maryam Kameli, Asal Hojjat,